Allianz Asset Management
OPTR

Allianz Asset Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Allianz Asset Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-164,050
Closed -$2.06M – 1982
2013
Q3 		$2.06M Sell
164,050
-63,000
-28% -$835K ﹤0.01% 1177
2013
Q2 		$3.29M Buy
+227,050
New +$3.31M ﹤0.01% 1040

Allianz Asset Management's OPTR Position: Q4 2013 in Review

Allianz Asset Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 164,050 shares — an estimated $2.06M sold.

Allianz Asset Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $3.29M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Allianz Asset Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Allianz Asset Management sold 164,050 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.06M.
  • Allianz Asset Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Allianz Asset Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.29M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Allianz Asset Management's 13F filing for Q4 2013, filed 13 Feb 2014.